Record NNP B-NP O
date NN I-NP O
: : O O
2086-08-02 CD O B-DATE
This DT B-NP O
is VBZ B-VP O
my PRP$ B-NP O
first JJ I-NP O
visit NN I-NP O
with IN B-PP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
, , O O
for IN B-PP O
whom WP B-NP O
this DT B-NP O
is VBZ B-VP O
a DT B-NP O
routine JJ I-NP O
physical NN I-NP O
. . O O
68 CD B-NP B-AGE
yo NNP I-NP O
pleasant JJ I-NP O
white JJ I-NP O
woman NN I-NP O
with IN B-PP O
the DT B-NP O
following JJ I-NP O
problems NNS I-NP O
: : O O
1 CD B-LST O
. . O O
Left VBD B-VP O
vertebral JJ B-NP O
stenosis NN I-NP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
presented VBD B-VP O
with IN B-PP O
ataxia NN B-NP O
and CC I-NP O
dizziness NN I-NP O
in IN B-PP O
2083 CD B-NP B-DATE
and CC O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
an DT B-NP O
infarct NN I-NP O
in IN B-PP O
the DT B-NP O
territory NN I-NP O
of IN B-PP O
the DT B-NP O
posterior JJ I-NP O
inferior JJ I-NP O
cerebellar NN I-NP O
artery NN I-NP O
. . O O
Work-up NNP B-NP O
revealed VBD B-VP O
left VBN I-VP O
vertebral JJ B-NP O
stenosis NN I-NP O
. . O O
She PRP B-NP O
recovered VBD B-VP O
after IN B-PP O
the DT B-NP O
event NN I-NP O
to TO B-PP O
her PRP$ B-NP O
baseline NN I-NP O
, , O O
and CC O O
now RB B-ADVP O
has VBZ B-VP O
no DT B-NP O
complaints NNS I-NP O
of IN B-PP O
HA NNP B-NP O
, , O O
dizziness NN B-NP O
, , O O
ataxia NN B-NP O
, , O O
paresthesias NNS B-NP O
, , O O
or CC O O
motor NN B-NP O
weakness NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
chronically RB I-VP O
anticoagulated VBN I-VP O
and CC I-VP O
followed VBN I-VP O
in IN B-PP O
coumadin NN B-NP O
clinic NN I-NP O
; : O O
recent JJ B-NP O
INR NN I-NP O
was VBD B-VP O
2.6. VBG I-VP O
2. . B-NP O
Hypertension NNP I-NP O
During IN B-PP O
her PRP$ B-NP O
2083 CD I-NP B-DATE
admission NN I-NP O
for IN B-PP O
CVA NNP B-NP O
, , O O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
severely RB B-ADJP O
hypertensive JJ I-ADJP O
. . O O
She PRP B-NP O
is VBZ B-VP O
now RB B-ADVP O
on IN B-PP O
Atenolol NNP B-NP O
75 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd NN I-NP O
and CC O O
Zestril NNP B-NP O
10 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd NN I-NP O
for IN B-PP O
control NN B-NP O
of IN B-PP O
her PRP$ B-NP O
hypertension NN I-NP O
. . O O
She PRP B-NP O
does VBZ B-VP O
not RB I-VP O
measure VB I-VP O
her PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
at IN B-PP O
home NN B-NP O
. . O O
3. DT B-NP O
Diabetes NNP I-NP O
mellitus NN I-NP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
has VBZ B-VP O
NIDDM NNP B-NP O
for IN B-PP O
which WDT B-NP O
she PRP B-NP O
takes VBZ B-VP O
Micronase NNP B-NP O
5 CD I-NP O
mg NN I-NP O
BID NNP I-NP O
with IN B-PP O
fairly RB B-NP O
good JJ I-NP O
control NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
no DT B-NP O
known JJ I-NP O
history NN I-NP O
of IN B-PP O
retinopathy NN B-NP O
, , O O
nephropathy NN B-NP O
, , O O
CAD NNP B-NP O
, , O O
or CC O O
neuropathy RB B-ADVP O
. . O O
She PRP B-NP O
has VBZ B-VP O
no DT B-NP O
complaints NNS I-NP O
of IN B-PP O
visual JJ B-NP O
changes NNS I-NP O
, , O O
chest NN B-NP O
pain/SOB NN I-NP O
, , O O
paresthesias NNS B-NP O
, , O O
or CC O O
bloating/early JJ B-NP O
satiety NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
noticed VBN I-VP O
some DT B-NP O
increase NN I-NP O
in IN B-PP O
thirst JJ B-NP O
( -LRB- I-NP O
7 CD I-NP O
glasses NNS I-NP O
of IN B-PP O
water/day NN B-NP O
) -RRB- O O
which WDT B-NP O
she PRP B-NP O
attributes VBZ B-VP O
to TO B-PP O
the DT B-NP O
heat NN I-NP O
and CC O O
she PRP B-NP O
has VBZ B-VP O
nocturia DT B-NP O
( -LRB- I-NP O
2x CD I-NP O
per IN B-PP O
night NN B-NP O
) -RRB- O O
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
stable JJ B-ADJP O
over IN B-PP O
a DT B-NP O
couple NN I-NP O
of IN B-PP O
years NNS B-NP O
. . O O
4 CD B-NP O
. . O O
Dyslipidemia NNP O O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
has VBZ B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
elevated JJ B-NP O
total JJ I-NP O
cholesterol NN I-NP O
; : O O
I PRP B-NP O
do VBP B-VP O
n't RB I-VP O
think VB I-VP O
she PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
a DT B-NP O
fasting JJ I-NP O
lipid JJ I-NP O
panel NN I-NP O
. . O O
5 CD B-NP O
. . O O
Benign NNP B-NP O
breast NN I-NP O
disease NN I-NP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
has VBZ B-VP O
diffusely RB B-NP O
fibronodular JJ I-NP O
breasts NNS I-NP O
. . O O
Microcalcifications NNS B-NP O
were VBD B-VP O
noted VBN I-VP O
on IN B-PP O
mammography NN B-NP O
and CC O O
bilateral JJ B-NP O
excisional JJ I-NP O
biopsies NNS I-NP O
revealed VBD B-VP O
benign JJ B-NP O
fibroadenoma NN I-NP O
without IN B-PP O
evidence NN B-NP O
of IN B-PP O
malignancy NN B-NP O
. . O O
Mammography NNP B-NP O
on IN B-PP O
7/28/8 CD B-NP I-DATE
6 CD I-NP I-DATE
was VBD B-VP O
normal JJ B-ADJP O
. . O O
6 CD B-NP O
. . O O
Skin NNP B-NP O
lesion NN I-NP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
has VBZ B-VP O
a DT B-NP O
skin NN I-NP O
lesion NN I-NP O
on IN B-PP O
her PRP$ B-NP O
right JJ I-NP O
temple NN I-NP O
which WDT B-NP O
has VBZ B-VP O
developed VBN I-VP O
over IN B-PP O
the DT B-NP O
course NN I-NP O
of IN B-PP O
a DT B-NP O
couple NN I-NP O
of IN B-PP O
months NNS B-NP O
. . O O
It PRP B-NP O
is VBZ B-VP O
slightly RB B-ADJP O
sore JJ I-ADJP O
to TO B-VP O
touch VB I-VP O
, , O O
and CC O O
is VBZ B-VP O
non-pruritic JJ B-NP O
and CC O O
does VBZ B-VP O
not RB I-VP O
bleed VB I-VP O
. . O O
ROS NNP B-NP O
: : O O
No DT B-NP O
HA NNP I-NP O
, , I-NP O
dizziness NN I-NP O
, , I-NP O
ataxia NN I-NP O
, , O O
hearing VBG B-VP O
loss NN B-NP O
, , O O
vision NN B-NP O
changes NNS I-NP O
, , O O
chest NN B-NP O
pain/pressure NN I-NP O
, , O O
SOB NNP B-NP O
, , O O
leg NN B-NP O
swelling VBG I-NP O
, , I-NP O
PND/orthopnea NNP I-NP O
, , I-NP O
diarrhea NN I-NP O
, , I-NP O
nausea/vomiting NN I-NP O
, , I-NP O
dysuria NN I-NP O
, , I-NP O
incontinence NN I-NP O
, , I-NP O
paresthesias NNS I-NP O
, , I-NP O
arthralgias NNS I-NP O
, , I-NP O
rash NN I-NP O
, , I-NP O
fevers NNS I-NP O
, , I-NP O
cold JJ I-NP O
or CC I-NP O
heat NN I-NP O
intolerance NN I-NP O
. . B-NP O
Does VBZ B-VP O
complain VB I-VP O
of IN B-PP O
mild JJ B-NP O
chronic JJ I-NP O
dry JJ I-NP O
cough NN I-NP O
. . O O
Health NNP B-NP O
maintenance NN I-NP O
: : O O
No DT B-NP O
ASA NNP I-NP O
( -LRB- I-NP O
on IN B-PP O
Coumadin NNP B-NP O
) -RRB- O O
No DT B-NP O
recent JJ I-NP O
pneumovax/influenza NN I-NP O
No DT B-NP O
tetanus JJ I-NP O
vaccine NN I-NP O
within IN B-PP O
10 CD B-NP O
yrs NNS I-NP O
Does VBZ B-VP O
not RB I-VP O
do VB I-VP O
regular JJ B-NP O
breast NN I-NP O
exams NNS I-NP O
, , O O
mammography NN B-NP O
7/28/8 CD I-NP I-DATE
6 CD O I-DATE
No DT B-NP O
recent JJ I-NP O
stool NN I-NP O
guaiac NN I-NP O
, , O O
has VBZ B-VP O
never RB I-VP O
had VBD I-VP O
endoscopy NN B-NP O
Has NNP B-NP O
never RB B-ADVP O
had VBD B-VP O
pap NN B-NP O
smear NN I-NP O
PMH: . O O
PICA NNP B-NP O
infarct NN I-NP O
in IN B-PP O
'83 CD B-NP B-DATE
Left VBN B-NP O
vertebral JJ I-NP O
stenosis NN I-NP O
NIDDM . O O
HTN . O O
dyslipidemia NN B-NP O
R NN B-NP O
cataract NN I-NP O
removal NN I-NP O
s/p JJ B-NP O
breast NN I-NP O
biopsy NN I-NP O
: : O O
benign JJ B-NP O
fibroadenoma NN I-NP O
Family NNP B-NP O
hx NN I-NP O
: : O O
Mother NNP B-NP O
died VBD B-VP O
of IN B-PP O
MI NNP B-NP O
age NN I-NP O
45 CD O B-AGE
Father NNP B-NP O
died VBD B-VP O
of IN B-PP O
MI NNP B-NP O
age NN I-NP O
72 CD O B-AGE
No DT B-NP O
family NN I-NP O
hx VBD B-VP O
colon NN B-NP O
CA NNP I-NP O
Social JJ B-NP O
history NN I-NP O
: : O O
50 CD B-NP O
pack NN I-NP O
year NN I-NP O
hx NN I-NP O
, , O O
quit VBD B-VP O
2081 CD I-VP B-DATE
Rare NNP B-NP O
ETOH NNP I-NP O
Lives NNS B-NP O
with IN B-PP O
son NN B-NP O
, , O O
several JJ B-NP O
children NNS I-NP O
in IN B-PP O
area NN B-NP O
Retired VBN O O
All DT B-NP O
: : O O
NKDA NNP O O
Medications NNS B-NP O
: : O O
MICRONASE NNP B-NP O
( -LRB- I-NP O
GLYBURIDE NNP I-NP O
) -RRB- I-NP O
5MG . I-NP O
PO NNP I-NP O
BID NNP I-NP O
ATENOLOL NNP B-NP O
75 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD NNP I-NP O
8/02/8 VBD B-VP I-DATE
6 CD O I-DATE
COUMADIN NNP B-NP O
( -LRB- I-NP O
WARFARIN NNP I-NP O
SODIUM) NNP I-NP O
PO NNP I-NP O
ZESTRIL NNP B-NP O
( -LRB- I-NP O
LISINOPRIL NNP I-NP O
) -RRB- I-NP O
10MG . I-NP O
PO NNP I-NP O
QD . O O
PE NN B-NP O
: : O O
Obese JJ B-NP O
woman NN I-NP O
in IN B-PP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
VS NNP B-NP O
: : O O
BP NNP B-NP O
170/90 CD I-NP O
HR NNP I-NP O
74 CD I-NP O
T NNP I-NP O
97.8 CD I-NP O
Weight NNP I-NP O
191 CD I-NP O
lbs NNS I-NP O
HEENT NNP B-NP O
: : O O
No DT B-NP O
scleral JJ I-NP O
icterus NN I-NP O
; : O O
fundi NN B-NP O
without IN B-PP O
hemorrhage NN B-NP O
, , O O
exudate NN B-NP O
, , O O
copper NN B-NP O
wiring NN I-NP O
or CC I-NP O
AV NN I-NP O
nicking NN I-NP O
; : O O
ear NN B-NP O
canals NNS I-NP O
occluded VBD B-VP O
with IN B-PP O
cerumen NNS B-NP O
; : O O
OP NNP B-NP O
no DT B-NP O
lesions NNS I-NP O
; : O O
no DT B-NP O
thyromegaly NN I-NP O
; : O O
no DT B-NP O
LAD NN I-NP O
; : O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
CV NNP B-NP O
: : O O
PMI NNP B-NP O
not RB I-NP O
palpable JJ I-NP O
, , I-NP O
regular JJ I-NP O
rate NN I-NP O
and CC I-NP O
rhythm NN I-NP O
, , O O
S2 NNP B-NP O
with IN B-PP O
physiological JJ B-NP O
splitting NN I-NP O
, , O O
no DT B-NP O
murmer/rubs/gallops NNS I-NP O
CHEST NNP B-NP O
: : O O
Lungs NNP B-NP O
resonant NN I-NP O
to TO B-PP O
percussion NN B-NP O
, , O O
clear JJ B-ADJP O
to TO B-PP O
auscultation NN B-NP O
, , O O
without IN B-PP O
wheezes NNS B-NP O
or CC I-NP O
crackles NNS I-NP O
Breasts NNS B-NP O
diffusely JJ I-NP O
nodular NN I-NP O
, , O O
no DT B-NP O
asymmetry/dimpling/discharge NN I-NP O
, , O O
bilateral JJ B-NP O
scars NNS I-NP O
from IN B-PP O
excisional JJ B-NP O
biopsies NNS I-NP O
ABD NNP B-NP O
: : O O
Soft NNP B-NP O
, , O O
nontender NN B-NP O
, , O O
nondistended VBD B-VP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
no DT B-NP O
hepatomegaly NN I-NP O
or CC I-NP O
spleen JJ I-NP O
tip NN I-NP O
palpable NN I-NP O
, , O O
no DT B-NP O
abdominal NN I-NP O
bruits NNS I-NP O
EXT NNP B-NP O
: : O O
Trace NNP B-NP O
LE NNP I-NP O
edema NN I-NP O
to TO B-PP O
ankles NNS B-NP O
, , O O
no DT B-NP O
cyanosis NN I-NP O
or CC O O
clubbing VBG O O
SKIN JJ B-NP O
: : O O
Keratotic NNP B-NP O
1 CD I-NP O
cm NN I-NP O
lesion NN I-NP O
on IN B-PP O
R NN B-NP O
temple NN I-NP O
NEURO NNP B-NP O
: : O O
PERRL NN B-NP O
, , O O
CN NNP B-NP O
II-VII NNP I-NP O
I PRP B-NP O
and CC O O
XII NNP B-NP O
tested VBD B-VP O
and CC O O
intact JJ B-NP O
, , O O
motor NN B-NP O
strength NN I-NP O
5/5 VBD B-VP O
throughout IN B-ADVP O
, , O O
light JJ B-NP O
touch NN I-NP O
sensation NN I-NP O
intact JJ B-ADJP O
in IN B-PP O
distal JJ B-NP O
extremities NNS I-NP O
, , O O
finger-nose NN B-NP O
and CC I-NP O
heel/shin NN I-NP O
testing NN I-NP O
intact JJ O O
RECTAL/GU JJ B-NP O
: : O O
deferred VBN O O
Tests NNS B-NP O
: : O O
UA NN B-NP O
negative JJ I-NP O
( -LRB- I-NP O
including VBG I-NP O
protein NN I-NP O
) -RRB- O O
Fasting VBG B-VP O
lipid JJ B-NP O
panel NN I-NP O
, , O O
CBC NNP B-NP O
, , O O
Chem NNP B-NP O
7 CD I-NP O
, , O O
HbA1C NNP B-NP O
pending VBG I-NP O
Impression NN B-NP O
by IN B-PP O
problem NN B-NP O
: : O O
1 CD B-LST O
. . O O
Left VBD B-VP O
vertebral JJ B-NP O
stenosis NN I-NP O
: : O O
Patient NNP B-NP O
has VBZ B-VP O
not RB I-VP O
had VBN I-VP O
recurrent JJ B-NP O
symptoms NNS I-NP O
since IN B-PP O
her PRP$ B-NP O
CVA NNP I-NP O
in IN B-PP O
2083 CD B-NP B-DATE
and CC O O
she PRP B-NP O
is VBZ B-VP O
neurologically RB B-ADJP O
intact JJ I-ADJP O
by IN B-PP O
my PRP$ B-NP O
neuro NN I-NP O
exam NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
therapeutic JJ B-ADJP O
on IN B-PP O
her PRP$ B-NP O
coumadin NN I-NP O
. . O O
She PRP B-NP O
will MD B-VP O
continue VB I-VP O
coumadin NN B-NP O
and CC O O
I PRP B-NP O
will MD B-VP O
attempt VB I-VP O
to TO I-VP O
address VB I-VP O
CVA DT B-NP O
risk NN I-NP O
factors NNS I-NP O
such JJ B-PP O
as IN I-PP O
HTN NNP B-NP O
and CC I-NP O
dyslipidemia NN I-NP O
( -LRB- I-NP O
will MD B-VP O
avoid VB I-VP O
lowering VBG I-VP O
BP NNP B-NP O
excessively RB I-NP O
to TO B-VP O
preserve VB I-VP O
vertebral JJ B-NP O
perfusion NN I-NP O
) -RRB- I-NP O
. . O O
2. DT B-NP O
Hypertension NNP I-NP O
: : O O
Patient NNP B-NP O
is VBZ B-VP O
quite RB B-ADJP O
hypertensive JJ I-ADJP O
( -LRB- B-PP O
170/90 CD B-NP O
) -RRB- I-NP O
on IN B-PP O
current JJ B-NP O
regimen NNS I-NP O
of IN B-PP O
Atenolol NNP B-NP O
75 CD I-NP O
mg NN I-NP O
qd NN I-NP O
and CC O O
Zestril NNP B-NP O
10 CD I-NP O
mg NN I-NP O
qd NN I-NP O
. . O O
Her PRP$ B-NP O
heart NN I-NP O
rate NN I-NP O
is VBZ B-VP O
74 CD B-NP O
; : O O
I PRP B-NP O
will MD B-VP O
increase VB I-VP O
her PRP$ B-NP O
Atenolol NNP I-NP O
to TO B-PP O
100 CD B-NP O
mg CD I-NP O
qd NN I-NP O
. . O O
She PRP B-NP O
does VBZ B-VP O
not RB I-VP O
complain VB I-VP O
of IN B-PP O
any DT B-NP O
side NN I-NP O
effects NNS I-NP O
from IN B-PP O
her PRP$ B-NP O
medications NNS I-NP O
. . O O
She PRP B-NP O
does VBZ B-VP O
have VB I-VP O
a DT B-NP O
chronic NN I-NP O
, , O O
mild JJ B-NP O
dry JJ I-NP O
cough NN I-NP O
which WDT B-NP O
is VBZ B-VP O
possibly RB I-VP O
related VBN I-VP O
to TO B-PP O
her PRP$ B-NP O
Zestril NNP I-NP O
. . O O
3. . B-NP O
Diabetes NNP I-NP O
Mellitus NNP I-NP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
takes VBZ B-VP O
Micronase NNP B-NP O
5 CD I-NP O
mg NN I-NP O
BID NNP B-NP O
for IN B-PP O
blood NN B-NP O
sugar NN I-NP O
control NN I-NP O
; : O O
she PRP B-NP O
does VBZ B-VP O
not RB I-VP O
measure VB I-VP O
her PRP$ B-NP O
glucose NN I-NP O
at IN B-PP O
home NN B-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
a DT B-NP O
little JJ I-NP O
polydipsia/polyuria NN I-NP O
. . O O
Today NN B-NP O
I PRP B-NP O
will MD B-VP O
check VB I-VP O
a DT B-NP O
glucose NN I-NP O
and CC I-NP O
HbA1c JJ I-NP O
level NN I-NP O
. . B-PP O
Her PRP$ B-NP O
UA NNP I-NP O
today NN I-NP O
is VBZ B-VP O
negative JJ B-ADJP O
and CC O O
I PRP B-NP O
will MD B-VP O
check VB I-VP O
a DT B-NP O
spot NN I-NP O
urine JJ I-NP O
microalbumin/Cr NN I-NP O
ratio NN I-NP O
. . O O
On IN B-PP O
her PRP$ B-NP O
next JJ I-NP O
visit NN I-NP O
I PRP B-NP O
will MD B-VP O
schedule VB I-VP O
an DT B-NP O
ophthalmology NN I-NP O
appointment NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
on IN B-PP O
an DT B-NP O
ACE NNP I-NP O
inhibitor NN I-NP O
. . O O
4 CD B-NP O
. . O O
Dyslipidemia NNP O O
The DT B-NP O
patient NN I-NP O
has VBZ B-VP O
had VBN I-VP O
a DT B-NP O
recent JJ I-NP O
cholesterol NN I-NP O
of IN B-PP O
206 CD B-NP O
. . O O
I PRP B-NP O
will MD B-VP O
obtain VB I-VP O
a DT B-NP O
fasting JJ I-NP O
lipid JJ I-NP O
panel NN I-NP O
. . O O
5 CD B-NP O
. . O O
Benign NNP B-NP O
breast NN I-NP O
disease NN I-NP O
Excisional NNP B-NP O
biopsy NN I-NP O
showed VBD B-VP O
benign JJ B-NP O
fibroadenoma NN I-NP O
, , O O
mammography NN B-NP O
on IN B-PP O
7/28/8 CD B-NP I-DATE
6 CD I-NP I-DATE
was VBD B-VP O
normal JJ B-ADJP O
. . O O
She PRP B-NP O
has VBZ B-VP O
diffuse JJ B-NP O
fibronodular JJ I-NP O
disease NN I-NP O
on IN B-PP O
exam NN B-NP O
today NN B-NP O
. . O O
I PRP B-NP O
have VBP B-VP O
instructed VBN I-VP O
her PRP$ B-NP O
in IN B-PP O
self-examination NN B-NP O
. . O O
6 CD B-NP O
. . O O
Skin NNP B-NP O
lesion NN I-NP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
' POS B-NP O
skin NN I-NP O
lesion NN I-NP O
looks VBZ B-VP O
like IN B-PP O
it PRP B-NP O
may MD B-VP O
be VB I-VP O
a DT B-NP O
suborrheic JJ I-NP O
keratosis NN I-NP O
or CC O O
squamous JJ B-NP O
cell NN I-NP O
. . O O
I PRP B-NP O
will MD B-VP O
refer VB I-VP O
to TO B-PP O
a DT B-NP O
dermatologist NN I-NP O
. . O O
7. VBG B-VP O
Health NNP B-NP O
maintenance NN I-NP O
I PRP B-NP O
discussed VBD B-VP O
both DT B-NP O
hormone NN I-NP O
replacement NN I-NP O
therapy NN I-NP O
and CC I-NP O
screening NN I-NP O
flexible JJ I-NP O
sigmoidoscopy NN I-NP O
with IN B-PP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
and CC O O
she PRP B-NP O
has VBZ B-VP O
declined VBN I-VP O
both DT B-NP O
. . B-VP O
She PRP B-NP O
also RB B-ADVP O
does VBZ B-VP O
not RB I-VP O
want VB I-VP O
a DT B-NP O
pneumovax NN I-NP O
today NN I-NP O
, , O O
although IN B-SBAR O
she PRP B-NP O
is VBZ B-VP O
willing JJ B-ADJP O
to TO B-VP O
have VB I-VP O
her PRP$ B-NP O
tetanus NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
also RB I-VP O
agreed VBN I-VP O
to TO I-VP O
start VB I-VP O
taking VBG B-NP O
calcium/vitamin NN I-NP O
D NNP I-NP O
as RB B-ADVP O
well RB I-ADVP O
as IN B-PP O
an DT B-NP O
MVI. NNP I-NP O
She PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
recent JJ B-NP O
mammography NN I-NP O
. . O O
Follow-up NN B-NP O
: : O O
I PRP B-NP O
will MD B-VP O
see VB I-VP O
Ms. NNP B-NP O
Ordonez NNP I-NP B-PATIENT
in IN B-PP O
one CD B-NP O
month NN I-NP O
to TO B-VP O
check VB I-VP O
her PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
on IN B-PP O
her PRP$ B-NP O
increased JJ I-NP O
dose NN I-NP O
of IN B-PP O
Atenolol NNP B-NP O
. . O O
